JOHN L. HIGGINS - 12 Sep 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
12 Sep 2024
Net transactions value
+$523
Form type
4
Filing time
16 Sep 2024, 16:18:34 UTC
Previous filing
10 Jul 2024
Next filing
28 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $137,700 +6,000 +14% $22.95 48,608 12 Sep 2024 Direct
transaction TECH Common Stock Tax liability $137,177 -1,874 -3.9% $73.20 46,734 12 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -6,000 -100% $0.000000 0 12 Sep 2024 Common Stock 6,000 $22.95 Direct
holding TECH Stock Options (Right to Buy) 17,040 12 Sep 2024 Common Stock 17,040 $21.84 Direct
holding TECH Stock Options (Right to Buy) 15,940 12 Sep 2024 Common Stock 15,940 $25.30 Direct
holding TECH Stock Options (Right to Buy) 12,500 12 Sep 2024 Common Stock 12,500 $31.26 Direct
holding TECH Stock Options (Right to Buy) 7,592 12 Sep 2024 Common Stock 7,592 $44.96 Direct
holding TECH Stock Options (Right to Buy) 8,044 12 Sep 2024 Common Stock 8,044 $50.41 Direct
holding TECH Stock Options (Right to Buy) 6,028 12 Sep 2024 Common Stock 6,028 $63.92 Direct
holding TECH Stock Options (Right to Buy) 2,532 12 Sep 2024 Common Stock 2,532 $128.81 Direct
holding TECH Stock Options (Right to Buy) 3,460 12 Sep 2024 Common Stock 3,460 $73.94 Direct
holding TECH Stock Options (Right to Buy) 3,937 12 Sep 2024 Common Stock 3,937 $61.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.